![Triptan Use in Adults With Cardiovascular Risk]()
by Sue Robbins | Nov 27, 2016 | Headache Drugs, Migraine
Read more here.
![Triptan Use in Adults With Cardiovascular Risk]()
by Sue Robbins | Sep 18, 2016 | Migraine
The month’s best new evidence on Headache, September, 2016. Read more here…
![Triptan Use in Adults With Cardiovascular Risk]()
by Sue Robbins | Mar 28, 2016 | Headache Drugs
Wsj.com reporter Jonathan D. Rockoff reports on new medicines, now in late stages of development for migraine pain… Researchers are unlocking some of the mysteries surrounding migraines, raising hopes for a new class of treatments. Millions of patients who...
![Triptan Use in Adults With Cardiovascular Risk]()
by Sue Robbins | Feb 1, 2016 | Migraine
The US Food and Drug Administration (FDA) has approved a low-dose sumatriptan powder delivered intranasally for the treatment of migraine with or without aura in adult patients. “Onzetra Xsail provides a new and much needed treatment option for what can be a...
![Triptan Use in Adults With Cardiovascular Risk]()
by Sue Robbins | Aug 12, 2015 | Adolescents and Children, Migraine
Migraine is a common issue among children and teens, but a new study says that too few receive appropriate treatment. This is especially true in urban areas, according to Robert A. Nicholson, PhD, of Mercy Clinic Headache Center & Mercy Health Research in St....
